Cuba will seek WHO endorsement for its anticovid-19 vaccines |  News

Cuba is getting ready for the meeting next Thursday with representatives of the World Health Organization (WHO) in which it will try to obtain international recognition of the vaccines against the coronavirus developed by the Caribbean country.

READ ALSO:

Cuba leads the list of countries with the most vaccinated against Covid-19

The Director of Science and Innovation of BioCubaFarma, Rolando Pérez indicated that after the next meeting, WHO experts will begin to evaluate the documentation delivered on the anti-Covid-19 vaccines.

Previously, the representative of the Pan American and World Health Organization (PAHO / WHO) in Havana, José Moya, explained that a work team will be established to review the results of clinical trials, production processes and quality of the three Cuban vaccines against the coronavirus.

The Cuban vaccines Abdala, Soberana 02 and Soberana Plus were the first in Latin America to receive authorization from national regulatory authorities for emergency use.

The Abdala vaccine, developed by the Center for Genetic Engineering and Biotechnology (CIGB), demonstrated 92.2 percent efficacy against coronavirus in its clinical trials.

For its part, Soberana 02 plus a reinforcement of its counterpart Soberana Plus, both from the Finlay Vaccine Institute (IFV), showed 91.2 percent efficacy during clinical trials.

On several occasions, PAHO has recognized Cuba’s efforts in the development of Covid-19 vaccines and their importance for the region.

Cuban vaccines are already used in some nations as part of bilateral agreements and collaboration in the development of clinical studies, while the vaccination process with them advances throughout the Cuban territory.

Leave a Reply